Related Experiment Video
Updated: Jan 28, 2026

Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
Published on: December 14, 2017
Caught in the act: LRRK2 in exosomes
1Duke Center for Neurodegeneration and Neurotherapeutics, Duke University, Durham, NC 27710, U.S.A.
Abstract:
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a frequent genetic cause of late-onset Parkinson's disease (PD) and a target for therapeutic approaches. LRRK2 protein can influence vesicle trafficking events in the cytosol, with action both in endosomal and lysosomal pathways in different types of cells. A subset of late endosomes harbor intraluminal vesicles that can be secreted into the extracellular milieu. These extracellular vesicles, called exosomes, package LRRK2 protein for transport outside the cell into easily accessed biofluids. Both the cytoplasmic complement of LRRK2 as well as the exosome-associated fraction of protein appears regulated in part by interactions with 14-3-3 proteins. LRRK2 inside exosomes have disease-linked post-translational modifications and are relatively stable compared with unprotected proteins in the extracellular space or disrupted cytosolic compartments. Herein, we review the biology of exosome-associated LRRK2 and the potential for utility in diagnosis, prognosis, and theragnosis in PD and other LRRK2-linked diseases.
Insights
Mutations in leucine-rich repeat kinase 2 (LRRK2) are linked to Parkinson's disease. LRRK2 protein is found in exosomes, offering potential for disease diagnosis and therapy.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common genetic cause of late-onset Parkinson's disease (PD).
- LRRK2 protein plays a role in cellular vesicle trafficking, including endosomal and lysosomal pathways.
- Extracellular vesicles, specifically exosomes, can package and transport LRRK2 protein outside the cell.
Purpose of the Study:
- To review the biology of exosome-associated LRRK2.
- To explore the potential utility of exosome-associated LRRK2 in Parkinson's disease diagnosis, prognosis, and theranosis.
Main Methods:
- Literature review of studies investigating LRRK2 protein, exosomes, and Parkinson's disease.
- Analysis of LRRK2's role in vesicle trafficking and its presence in exosomes.
- Examination of disease-linked modifications and stability of exosomal LRRK2.
Main Results:
- LRRK2 protein is packaged into exosomes, which are secreted into biofluids.
- Exosomal LRRK2 can carry disease-linked post-translational modifications.
- Exosomal LRRK2 is relatively stable in the extracellular environment.
Conclusions:
- Exosome-associated LRRK2 represents a promising biomarker for Parkinson's disease.
- LRRK2 within exosomes may serve diagnostic, prognostic, and therapeutic roles in LRRK2-linked diseases.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Nuclear Export of mRNA
Social Traps
Longitudinal Research
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Robbers Cave

